APOE and Alzheimer disease: This study explored the effects of individual APOE ε4 status on the performance of a novel MRI-based biomarker based on the recently presented BrainAGE framework [15, 55] in (i) recognizing advanced brain aging in a longitudinal design and (ii) predicting prospective conversion to AD on an individual subject level.